An Act to provide rapid whole genome sequencing

This bill directs Massachusetts state health officials to cover rapid whole genome sequencing for Medicaid patients under 22 who have complex or acute illnesses with unknown causes. The legislation defines this testing as a method to analyze the entire human genome and requires results to be available within 14 days, specifically for children in intensive care or high-acuity units. Coverage is authorized only when specific clinical criteria are met, such as multiple organ system anomalies, abnormal lab results suggesting genetic disorders, or severe conditions like refractory seizures and abnormal heart function. The law mandates that the resulting genetic data be used primarily to guide patient diagnosis and treatment while remaining protected under standard health privacy regulations.